60 results
6-K
EX-99.1
BLU
Bellus Health Inc
2 Jun 23
Notice of Annual and Special Meeting of Shareholders
4:25pm
satisfaction and to assess the organization/relationship with management, rewards and acknowledgement, compensation and benefits, satisfaction and motivation
6-K
EX-99.1
BLU
Bellus Health Inc
19 May 23
Current report (foreign)
5:27pm
of 2023 or earlier, subject to satisfaction of all closing conditions.
Termination Fee: The Board of Directors retains the ability, in certain … as the satisfaction or waiver of all other conditions precedent to the Arrangement, it is anticipated that the Arrangement will be completed in the third quarter
6-K
EX-99.2
BLU
Bellus Health Inc
12 May 23
Condensed Consolidated Interim Financial Statements of
4:32pm
in our studied patient population to the satisfaction of relevant regulatory agencies;
the function, potential benefits, tolerability profile
6-K
EX-99.1
BLU
Bellus Health Inc
12 May 23
BELLUS Health Reports First Quarter 2023 Financial Results and Business Highlights
4:02pm
, the ability of BELLUS Health to validate its use of the VitaloJAK cough monitoring system to the satisfaction of relevant regulatory agencies, the potential
6-K
EX-99.2
BLU
Bellus Health Inc
27 Apr 23
Material Change Report
6:04am
6.5
Deemed Satisfaction of Conditions
ARTICLE VII TERMINATION
Section 7.1
Termination and Abandonment
Section 7.2
Effect of Termination/Survival … ) on the third (3rd) Business Day after the satisfaction, or where not prohibited, the waiver by the applicable Party or Parties in whose favor
6-K
EX-99.1
9u9zv0j
5 Apr 23
BELLUS Health Announces Positive Results from its Phase 1 Bioavailability Equivalence Study Evaluating
7:01am
6-K
EX-99.2
7d5t fnmt4x
30 Mar 23
Notice of Annual and Special Meeting of Shareholders
11:22am
6-K
EX-99.1
tzvt2y6h95nasj
29 Mar 23
Current report (foreign)
5:26pm
6-K
EX-99.2
ycq6wxauv7o
14 Nov 22
Condensed Consolidated Interim Financial Statements of
5:26pm
SUPPL
8txx4 aw8edy6w
14 Nov 22
Supplemental materials (foreign)
5:25pm
6-K
EX-99.1
p4do1f
14 Nov 22
Open Market Sale Agreementsm
5:19pm
6-K
EX-99.1
ode1ugh
14 Nov 22
BELLUS Health Reports Third Quarter 2022 Financial Results and Business Highlights
4:03pm
6-K
EX-99.1
1pk22gwiadis
16 Sep 22
Investor Presentation NASDAQ/TSX - BLU September 16 th , 2022
4:40pm
F-10
0p9ddomt
26 Aug 22
Registration of securities (Canada)
4:48pm
SUPPL
o4wtah5cvev
15 Jul 22
Supplemental materials (foreign)
7:01am
6-K
EX-99.1
imx wxgao8ua
14 Jul 22
BELLUS Health Announces Pricing of US$153 Million Public Offering in Canada and the United States
4:46pm
6-K
EX-99.2
hb9q peo52
14 Jul 22
BELLUS Health Announces Pricing of US$153 Million Public Offering in Canada and the United States
4:46pm
SUPPL
xr67f7wzynuhsmkegfp2
13 Jul 22
Supplemental materials (foreign)
5:01pm
S-8
EX-5.1
orcwjrbb4ljlp
19 Apr 22
Registration of securities for employees
4:14pm
S-8 POS
EX-4.1
5okfih r4c
19 Apr 22
Registration of securities for employees (post-effective amendment)
4:10pm